Minerva Surgical, Inc. – NASDAQ:UTRS
Minerva Surgical stock price monthly change
Minerva Surgical stock price quarterly change
Minerva Surgical stock price yearly change
Minerva Surgical key metrics
Market Cap | 888 |
Enterprise value | 39.58M |
P/E | -0.16 |
EV/Sales | 0.51 |
EV/EBITDA | -1.95 |
Price/Sales | 0.08 |
Price/Book | 0.39 |
PEG ratio | 0.08 |
EPS | -4.81 |
Revenue | 51.69M |
EBITDA | -27.10M |
Income | -35.55M |
Revenue Q/Q | -4.94% |
Revenue Y/Y | 3.10% |
Profit margin | -37.6% |
Oper. margin | -55.2% |
Gross margin | 55.54% |
EBIT margin | -55.2% |
EBITDA margin | -52.44% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMinerva Surgical stock price history
Minerva Surgical stock forecast
Minerva Surgical financial statements
| Dec 2022 | 13.80M | -6.24M | -45.24% |
|---|---|---|---|
| Mar 2023 | 12.53M | -13.44M | -107.27% |
| Jun 2023 | 13.39M | -8.68M | -64.83% |
| Sep 2023 | 11.96M | -7.18M | -60.02% |
| 2025 | 69.55M | -27.03M | -38.88% |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 68900000 | 51.71M | 75.06% |
|---|---|---|---|
| Mar 2023 | 85168000 | 51.09M | 60% |
| Jun 2023 | 79303000 | 52.71M | 66.47% |
| Sep 2023 | 72785000 | 52.53M | 72.17% |
| Dec 2022 | -15.64M | 52K | 2K |
|---|---|---|---|
| Mar 2023 | -8.38M | -75K | 26.77M |
| Jun 2023 | -9.60M | -13K | 79K |
| Sep 2023 | -5.09M | -17K | 0 |
Minerva Surgical alternative data
| Aug 2023 | 174 |
|---|---|
| Sep 2023 | 174 |
| Oct 2023 | 174 |
| Nov 2023 | 174 |
| Dec 2023 | 174 |
| Jan 2024 | 174 |
| Feb 2024 | 174 |
| Mar 2024 | 174 |
| Apr 2024 | 174 |
| May 2024 | 174 |
| Jun 2024 | 174 |
| Jul 2024 | 174 |
Minerva Surgical other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2023 | 24437927 | 0 |
| Quarter | Transcript |
|---|---|
| Q2 2023 7 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 2 May 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 21 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 14 Nov 2022 | Q3 2022 Earnings Call Transcript |
-
When is Minerva Surgical's next earnings date?
Unfortunately, Minerva Surgical's (UTRS) next earnings date is currently unknown.
-
Does Minerva Surgical pay dividends?
No, Minerva Surgical does not pay dividends.
-
How much money does Minerva Surgical make?
Minerva Surgical has a market capitalization of 888 and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3.47% to 50.29M US dollars.
-
What is Minerva Surgical's stock symbol?
Minerva Surgical, Inc. is traded on the NASDAQ under the ticker symbol "UTRS".
-
What is Minerva Surgical's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Minerva Surgical?
Shares of Minerva Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Minerva Surgical have?
As Jul 2024, Minerva Surgical employs 174 workers.
-
When Minerva Surgical went public?
Minerva Surgical, Inc. is publicly traded company for more then 3 years since IPO on 22 Oct 2021.
-
What is Minerva Surgical's official website?
The official website for Minerva Surgical is minervasurgical.com.
-
Where are Minerva Surgical's headquarters?
Minerva Surgical is headquartered at 4255 Burton Drive, Santa Clara, CA.
-
How can i contact Minerva Surgical?
Minerva Surgical's mailing address is 4255 Burton Drive, Santa Clara, CA and company can be reached via phone at +855 6467874.
Minerva Surgical company profile:
Minerva Surgical, Inc.
minervasurgical.comNASDAQ
174
Medical - Healthcare Information Services
Healthcare
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Santa Clara, CA 95054
CIK: 0001452965
ISIN: US60343F1066
CUSIP: 60343F106
